MRSA Spurs New Interest In Antibiotics

Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according to infectious disease experts. However, the US FDA has asked for more information about a new antibiotic, ceftobiprole, from US-based

To read the full article, please take a trial.